Medpace
MEDP
348 hedge funds and large institutions have $4.48B invested in Medpace in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 123 increasing their positions, 155 reducing their positions, and 66 closing their positions.
50% more call options, than puts
Call options by funds: $18.7M | Put options by funds: $12.5M
1.39% more ownership
Funds ownership: 79.74% → 81.13% (+1.4%)
10% less funds holding
Funds holding: 385 → 348 (-37)
21% less repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 155
28% less capital invested
Capital invested by funds: $6.23B → $4.48B (-$1.76B)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
52% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
+$54.2M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$48.5M |
| 3 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$30.8M |
| 4 |
Millennium Management
New York
|
+$20.1M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
+$17.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$231M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$37.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$34.7M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$27.4M |
| 5 |
Polen Capital Management
Boca Raton,
Florida
|
-$18.7M |
MEDP Hedge Fund Activity: Q1 2022 in Review
348 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2022, worth a combined $4.48B — down 28% from $6.23B a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of MEDP and 32 opened new positions — a net loss of 34 holders — while 155 trimmed existing stakes and 123 added.
The largest buyer was Vulcan Value Partners, adding an estimated $54.2M. The largest seller was Wellington Management Group, exiting entirely with an estimated $231M sold.
- 348 institutional investors held Medpace (MEDP) as of Q1 2022, down from 385 in Q4 2021.
- Funds reported $4.48B of Medpace stock for Q1 2022, down 28% quarter-over-quarter.
- 32 funds opened new Medpace positions in Q1 2022 and 66 closed out, a net change of -34 holders.
- The largest Medpace buyer in Q1 2022 was Vulcan Value Partners, an estimated $54.2M added.
- The largest Medpace seller in Q1 2022 was Wellington Management Group, an estimated $231M sold.
Based on aggregated 13F filings for Q1 2022.